Comparison of effects of nebivolol, carvedilol and irbesartan on left ventricular hypertrophy associated with hypertension

DEĞİRMENCİ H., AÇIKEL M., BAKIRCI E. M., DUMAN H., DEMİRELLİ S., TAŞ M. H., ...Daha Fazla

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.18, sa.5, ss.630-637, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 5
  • Basım Tarihi: 2014
  • Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.630-637
  • Anahtar Kelimeler: New generation beta-blockers, Irbesartan, Left ventricular hypertrophy, PROGNOSTIC IMPLICATIONS, MASS, REGRESSION, ATENOLOL, HEART
  • Atatürk Üniversitesi Adresli: Evet

Özet

OBJECTIVES: The aim of this study was to investigate if the new generation beta-blockers are as effective as irbesartan, which is an angiotensin receptor blocker (ARB), on left ventricular hypertrophy (LVH).